MedTrace Logo

Use of Oxybutynin for Treating Hyperhidrosis: A Placebo-control Study

NCT01310712 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2011-09-22

No results posted yet for this study

Summary

Video-assisted thoracic sympathectomy (VATS) provides excellent resolution of palmar and axillary hyperhidrosis but is associated with compensatory hyperhidrosis. Low doses of Oxybutynin can be used to treat palmar hyperhidrosis with fewer side effects.

Conditions

  • Hyperhidrosis

Interventions

DRUG

Oxybutynin

5 mg every 12 hours for 6 weeks

DRUG

placebo

placebo twice a day for 42 days.

Sponsors & Collaborators

  • University of Sao Paulo

    lead OTHER

Principal Investigators

  • WOLOSKER NELSON, Md, PhD · University of Sao Paulo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2011-02-28
Completion
2011-03-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01310712 on ClinicalTrials.gov